- Trials with a EudraCT protocol (264)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
264 result(s) found for: Autologous Blood Injection.
Displaying page 1 of 14.
EudraCT Number: 2006-004521-28 | Sponsor Protocol Number: HHSC/010 | Start Date*: 2009-06-30 |
Sponsor Name:Imperial College London | ||
Full Title: A multi-centre phase I/II safety and tolerability study following the infusion of expanded autologous progeny of an adult CD34 positive stem cell subset to patients with recent tibial fractures. | ||
Medical condition: Fractured Tibia | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-017924-18 | Sponsor Protocol Number: P10 | Start Date*: 2011-01-04 |
Sponsor Name: | ||
Full Title: Efficacy assessment of repeat intramyocardial injection of autologous bone marrow cells in previously responding no-option patients with residual refractory angina pectoris and documented ischemia | ||
Medical condition: In coronary artery disease atherosclerosis leads to a decrease in lumen diameter of the large epicardial arteries, causing a deficit in blood flow known as ischemia. This ischemia can cause chest p... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005498-29 | Sponsor Protocol Number: 2.28 | Start Date*: 2013-03-21 |
Sponsor Name:Celica, Biomedical Center, d.o.o. | ||
Full Title: Preparation and application of autologous immunohybridoma cells for the treatment of prostate cancer | ||
Medical condition: Prostate cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: SI (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-003574-28 | Sponsor Protocol Number: THYTECH1-2018-005 | Start Date*: 2019-11-26 |
Sponsor Name:Rafael Correa Rocha | ||
Full Title: Phase I / II clinical trial, randomized, exploratory and prospective to evaluate the safety and efficacy of the transfusion of autologous TREG cells obtained from thymic tissue in the prevention of... | ||
Medical condition: To evaluate the efficacy in the prevention of the rejection of the transfusion of autologous thyTreg cells in children transplanted from the heart | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-004319-37 | Sponsor Protocol Number: 001.4 | Start Date*: 2019-06-19 | |||||||||||
Sponsor Name:Medical University of Vienna, Department of Surgery | |||||||||||||
Full Title: A prospective, randomised, single-blind explorative study to investigate the efficacy and safety of fat graft enrichment with autologous platelet lysate in female breast augmentation | |||||||||||||
Medical condition: Fat grafting e.g. to the breast to restore small tissue defects is a very common and safe surgical procedure. Its main success among other is depended on the survival rate of the transferred fat ti... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000640-91 | Sponsor Protocol Number: CMA-RC-03 | Start Date*: 2005-06-10 |
Sponsor Name:Institut de Recerca Hospital Sta. Creu i St. Pau | ||
Full Title: Treatment for acute myeloid leukemia (AML) during its first complete remision with the monoclonal antibody Mylotarg ® (anti-CD33/calicheamicina) pre- and post- autologous transplant of hematopoieti... | ||
Medical condition: Acute myeloid leukemia (AML) during its first complete remision and with high relapse risk, pre- and post- autologous hematopoiteic transplant | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-006962-41 | Sponsor Protocol Number: CSTI571ADE60 | Start Date*: 2008-03-27 |
Sponsor Name:Charité Universitätsmedizin Berlin | ||
Full Title: Dendritic cells as autologous vaccine in patients with chronic myeloid leukemia | ||
Medical condition: Chronic myeloid leukemia is a malignant disease of the blood. Without therapy it has an unfavourable prognosis. Under first-line therapy with newer inhibitors of the thymidinkinase some few patien... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2005-002657-45 | Sponsor Protocol Number: MSC1 | Start Date*: 2005-10-24 |
Sponsor Name:Cardiovascular laboratory 2014, Rigshospitalet | ||
Full Title: Mesenchymal stem cell therapy in patients with severe myocardial ischemia | ||
Medical condition: Chronic coronary artery disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-002985-34 | Sponsor Protocol Number: 03 | Start Date*: 2023-09-01 |
Sponsor Name:Boston Medical Group | ||
Full Title: EFFECTIVENESS AND SAFETY OF COMBINED AUTOLOGOUS PLATELET RICH PLASMA AND FOCAL SHOCKWAVE THERAPY FOR THE TREATMENT OF ERECTILE DYSFUNCTION | ||
Medical condition: Moderate or mild to moderate erectile dysfunction. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002210-36 | Sponsor Protocol Number: PR2006-03 | Start Date*: 2006-11-10 |
Sponsor Name:Queen Mary University of London | ||
Full Title: A Phase II study evaluating intravenous Melphalan with autologous whole blood stem cell transplantation (PBSCT) in patients with Androgen –Independent Prostate Cancer (AIPC) | ||
Medical condition: Open-labelled, non-randomised, treatment intensifying cohort study in androgen-independent prostate cancer (AIPC.) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-003652-37 | Sponsor Protocol Number: V212-001-00 | Start Date*: 2007-03-02 |
Sponsor Name:Merck & Co., Inc. | ||
Full Title: A Phase III, Double-Blind, Randomized, Placebo-Controlled, Multicenter Clinical Trial to Study the Safety, Tolerability, Efficacy, and Immunogenicity of V212/Heat-Treated Varicella-Zoster Virus (VZ... | ||
Medical condition: Herpes zoster (HZ). | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: CZ (Completed) DE (Completed) FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003952-63 | Sponsor Protocol Number: LIQUENIA | Start Date*: 2017-07-07 | |||||||||||
Sponsor Name:Instituto de Investigación Sanitaria La Fe | |||||||||||||
Full Title: Pilot study of vulval lichen sclerosus treatment by adipose tissue associated with autologous platelet-rich plasma | |||||||||||||
Medical condition: Vulval lichen sclerosus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000795-15 | Sponsor Protocol Number: MYVAC2 | Start Date*: 2014-01-29 | |||||||||||
Sponsor Name:UZ Brussel | |||||||||||||
Full Title: An open-label pilot clinical trial of MAGE-A3 and MAGE-C1 mRNA electroporated autologous dendritic cell vaccination in combination with lenalidomide maintenance therapy for multiple myeloma after f... | |||||||||||||
Medical condition: Symptomatic Multiple Myeloma after first-line autologous stem cell transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-000138-20 | Sponsor Protocol Number: 115523 | Start Date*: 2012-06-07 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A phase III, randomised, observer-blind, placebo-controlled, multicentre, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals’ herpes zoster gE/AS01B c... | |||||||||||||
Medical condition: Vaccination against herpes zoster (HZ) in adult autologous HCT recipients | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) ES (Completed) DE (Completed) FI (Completed) EE (Completed) IT (Completed) CZ (Completed) GB (Completed) FR (Completed) NL (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004034-41 | Sponsor Protocol Number: 21267983 | Start Date*: 2005-11-25 |
Sponsor Name:Genzyme Europe B.V. | ||
Full Title: Evaluation of Skeletal Myoblast Transplant for Treating Ischemic Heart Failure Phase 2 Study Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Study | ||
Medical condition: Ischemic Heart Failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-003418-28 | Sponsor Protocol Number: CLNA043X2201 | Start Date*: 2017-04-18 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, placebo-controlled, patient and investigator blinded, single dose, Proof of Concept study investigating the safety, tolerability and preliminary efficacy of intra-articular LNA043 in ... | |||||||||||||
Medical condition: Acute cartilage injuries | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-004110-10 | Sponsor Protocol Number: 2ABC | Start Date*: 2017-12-21 | ||||||||||||||||
Sponsor Name:Medical University of Warsaw | ||||||||||||||||||
Full Title: Evaluation the safety and efficacy of the treatment of scars and cutis laxa syndrome with the use of autologous (fresh and stored) stem cells isolated from adipose tissue within the project: 'The t... | ||||||||||||||||||
Medical condition: Scar or cutis laxa | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004067-31 | Sponsor Protocol Number: OA-orMSCp-02 | Start Date*: 2018-12-21 | ||||||||||||||||||||||||||
Sponsor Name:Bioinova, s.r.o. | ||||||||||||||||||||||||||||
Full Title: Autologous bone marrow-derived mesenchymal stem cells seeded on a 3D scaffold in treatment of knee cartilage defects. Prospective open-label study to assess safety and feasibility. | ||||||||||||||||||||||||||||
Medical condition: Knee Cartilage Defect | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: CZ (Completed) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005890-24 | Sponsor Protocol Number: HM05/7287 | Start Date*: 2007-11-02 | |||||||||||
Sponsor Name:Leeds Teaching Hospitals NHS Trust | |||||||||||||
Full Title: Myeloma X Relapse (Intensive) - A randomised controlled trial to determine the role of a second autologous stem cell transplant as consolidation therapy in patients with relapsed multiple myeloma f... | |||||||||||||
Medical condition: Relapsed myeloma previously treated with chemotherapy and autologous stem cell transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003555-11 | Sponsor Protocol Number: PD20180302 | Start Date*: 2021-04-19 |
Sponsor Name:ASSISTANCE PUBLIQUE-HOPÏTAUX DE PARIS | ||
Full Title: A Phase 1/2 Open Label non randomized Study, multicentric, single arm evaluating the Safety and Efficacy of Gene Therapy of the severe combined immunodeficiency (SCID) caused by mutations in the ... | ||
Medical condition: immunodeficiency (SCID) caused by mutations in the human DCLRE1C gene (Artemis) | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.